title: MET-Mutated NSCLC with Major Response to Crizotinib.
authors.affiliation: The David Geffen School of Medicine, University of California, Los Angeles, Santa Monica, California.
authors.forename: Melody A
authors.initials: MA
authors.lastname: Mendenhall
authors.affiliation: The David Geffen School of Medicine, University of California, Los Angeles, Santa Monica, California. Electronic address: jwgoldman@mednet.ucla.edu.
authors.forename: Jonathan W
authors.initials: JW
authors.lastname: Goldman
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000235:genetics; D000077547:Crizotinib; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics; D009154:Mutation; D019859:Proto-Oncogene Proteins c-met / Q000235:genetics*; D011720:Pyrazoles / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D019233:Retreatment
chemical_list: D000970:Antineoplastic Agents; D011720:Pyrazoles; D011725:Pyridines; D000077547:Crizotinib; C491743:MET protein, human; D019859:Proto-Oncogene Proteins c-met